Seattle company’s cannabis candies could fuel boom in stock shares
A popular Seattle cannabis manufacturer recently announced the roll-out of an all-new line of premium infused edibles, marketed under the brand name “Goodies.” Hand-crafted, gluten-free, and using all-natural ingredients, the candies and caramels contain micro-dose servings of just 5-mg THC for a controlled, measured experience.
Get a FREE report on new pot stock blockbuster

AIKI Insider Trading (AIkido Pharma)

Insider Ownership Percentage: 0.23%
Insider Buying (Last 12 Months): $29,100.00
Insider Selling (Last 12 Months): $0.00

AIkido Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at AIkido Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AIkido Pharma Share Price & Price History

Current Price: $0.88
Price Change: Price Decrease of -0.0025 (-0.28%)
As of 07/30/2021 04:56 PM ET

This chart shows the closing price history over time for AIKI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Three Cryptocurrencies to Hold in 2021
In 2021, Dogecoin went up over 12,000%. SafeMoon went up more than 20,000%...

But if you missed those gains, there is still time to get in on the digital currency boom.

Luke Lango – InvestorPlace’s resident crypto expert – just released the names of 3 tokens every investor should own in a free report.
Click here to claim your copy today.
pixel

AIkido Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2021Anthony HayesCEOBuy10,000$0.99$9,900.00
4/29/2021Anthony HayesCEOBuy10,000$0.99$9,900.0068,430View SEC Filing Icon  
4/22/2021Anthony HayesCEOBuy10,000$0.93$9,300.00
11/19/2018Anthony HayesCEOBuy10,000$0.88$8,800.0044,183View SEC Filing Icon  
See Full Table
Insider Selling at AIkido Pharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for AIkido Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for AIkido Pharma (NASDAQ:AIKI)

8.17% of AIkido Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AIKI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

AIkido Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2021Virtu Financial LLC195,885$0.22M0.0%+121.8%0.219%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC346,382$0.40M0.0%+310.2%0.387%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp44,191$50K0.0%N/A0.049%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp150,654$0.17M0.0%+417.6%0.169%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC615,177$0.70M0.0%+345.0%0.692%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,542,219$1.76M0.0%+2,753,862.5%1.735%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC88,326$77K0.0%N/A0.253%Search for SEC Filing on Google Icon
8/14/2020Sabby Management LLC342,121$0.28M0.1%N/A0.980%Search for SEC Filing on Google Icon
8/7/2020Virtu Financial LLC84,325$69K0.0%N/A0.241%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG101,063$83K0.0%N/A0.289%Search for SEC Filing on Google Icon
8/14/2019Citadel Advisors LLC13,870$35K0.0%-62.3%0.589%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.20,739$52K0.0%-76.5%0.881%Search for SEC Filing on Google Icon
2/9/2018Virtu Financial LLC79,986$0.11M0.0%+190.8%1.284%Search for SEC Filing on Google Icon
8/11/2017Virtu KCG Holdings LLC41,591$0.11M0.0%+78.0%0.841%Search for SEC Filing on Google Icon
1/13/2016Creative Planning0$00.0%-100.0%0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
AIkido Pharma logo
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.
Read More on AIkido Pharma

Today's Range

Now: $0.88
Low: $0.87
High: $0.89

50 Day Range

MA: $0.91
Low: $0.84
High: $1.02

52 Week Range

Now: $0.88
Low: $0.47
High: $2.55

Volume

9,410 shs

Average Volume

9,931,012 shs

Market Capitalization

$78.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55

Who are the company insiders with the largest holdings of AIkido Pharma?

AIkido Pharma's top insider investors include:
  1. Anthony Hayes (CEO)
Seattle company’s cannabis candies could fuel boom in stock shares
A popular Seattle cannabis manufacturer recently announced the roll-out of an all-new line of premium infused edibles, marketed under the brand name “Goodies.” Hand-crafted, gluten-free, and using all-natural ingredients, the candies and caramels contain micro-dose servings of just 5-mg THC for a controlled, measured experience.
Get a FREE report on new pot stock blockbuster